Ramelteon for the treatment of insomnia in menopausal women
Open Access
- 1 March 2009
- journal article
- research article
- Published by SAGE Publications in Menopause International
- Vol. 15 (1), 13-18
- https://doi.org/10.1258/mi.2009.009002
Abstract
Sleep disturbances have been reported to be one of the most troubling manifestations of menopause. While hormone replacement therapy (HRT) has historically been considered a first-line treatment for menopausal insomnia, many women are now seeking alternative treatments due to concerns about the risks and side-effects of HRT. The goal of this study was to evaluate the effect of ramelteon, a selective melatonin receptor agonist, for the treatment of menopausal insomnia. A total of 20 healthy peri- and postmenopausal women with insomnia participated in this six-week, prospective, open-label trial of ramelteon (8 mg) at an academic medical centre. Participants completed sleep–wake diaries on a daily basis for six weeks. Self-report measures of sleep impairment, daytime functioning, quality of life and mood were also completed on a bi-weekly basis. Significant improvements in latency to sleep onset, total sleep time and sleep efficiency were observed in diary data while gains in sleep quality, sleep impairment, daytime functioning, quality of life and mood were found in self-report measures. There was no evidence of tolerance or rebound over the course of the trial. Overall, results suggest that ramelteon is an effective non-hormonal approach for the treatment of insomnia in menopause. Randomized-controlled trials are needed to further evaluate the efficacy of this intervention.Keywords
This publication has 38 references indexed in Scilit:
- Eszopiclone in Patients With Insomnia During Perimenopause and Early PostmenopauseObstetrics & Gynecology, 2006
- Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomniaSleep Medicine, 2006
- An efficacy, safety, and dose–response study of Ramelteon in patients with chronic primary insomniaSleep Medicine, 2006
- Effects of exogenous melatonin on sleep: a meta-analysisSleep Medicine Reviews, 2005
- Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonistNeuropharmacology, 2005
- Women's sleep in health and diseaseJournal of Psychiatric Research, 2005
- Effect of Zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled studyClinical Therapeutics, 2004
- Botanical dietary supplement use in peri- and postmenopausal womenMenopause, 2003
- Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition *Menopause, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002